Kidul 30 Tablet contains Duloxetine 30 mg, a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. Duloxetine acts by increasing the levels of serotonin and norepinephrine in the central nervous system, which helps to improve mood, reduce anxiety, and alleviate pain associated with neuropathic and musculoskeletal conditions. This medication is typically administered orally once or twice daily, with or without food, as directed by a healthcare professional. Common side effects may include nausea, dry mouth, dizziness, fatigue, and constipation; patients should be monitored for any signs of worsening depression or suicidal ideation, especially during the initial treatment period or dosage adjustments. Duloxetine is contraindicated in patients with uncontrolled narrow-angle glaucoma, severe renal or hepatic impairment, and those currently taking monoamine oxidase inhibitors (MAOIs). Caution is advised when prescribing to individuals with a history of bipolar disorder, seizure disorders, or bleeding abnormalities. Kidul 30 Tablet should be used under strict medical supervision, with gradual dose adjustments and careful monitoring to optimize therapeutic outcomes and minimize adverse effects.